- Home
- RIGL vs YORW Comparison
RIGL vs YORW Comparison
Compare RIGL & YORW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RIGL | YORW |
|---|---|---|
| Founded | 1996 | 1816 |
| Country | United States | United States |
| Employees | N/A | 104 |
| Industry | Biotechnology: Pharmaceutical Preparations | Water Supply |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 564.7M | 507.5M |
| IPO Year | 2000 | 1994 |
Fundamental Metrics
Financial Performance| Metric | RIGL | YORW |
|---|---|---|
| Price | $39.16 | $31.54 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 1 |
| Target Price | ★ $45.67 | $34.00 |
| AVG Volume (30 Days) | ★ 302.4K | 150.7K |
| Earning Date | 05-05-2026 | 05-12-2026 |
| Dividend Yield | N/A | ★ 3.13% |
| EPS Growth | ★ 1867.68 | N/A |
| EPS | ★ 1.32 | 0.33 |
| Revenue | ★ $294,282,000.00 | $77,488,000.00 |
| Revenue This Year | N/A | $11.78 |
| Revenue Next Year | $12.75 | $4.95 |
| P/E Ratio | ★ $30.67 | $93.39 |
| Revenue Growth | ★ 64.15 | 3.37 |
| 52 Week Low | $24.84 | $28.26 |
| 52 Week High | $52.24 | $34.30 |
Technical Indicators
Market Signals| Indicator | RIGL | YORW |
|---|---|---|
| Relative Strength Index (RSI) | N/A | N/A |
| Support Level | N/A | N/A |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.00 | 0.00 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 0.00 | 0.00 |
Price Performance
Historical ComparisonAbout RIGL Rigel Pharmaceuticals Inc.
Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, REZLIDHIA (olutasidenib), GAVRETO (pralsetinib), R289, and Ocadusertib (Systemic) - Eli Lilly.
About YORW York Water Company (The)
The York Water Co is the investor-owned water utility in the United States. The primary business of the company is to impound, purify to meet or exceed safe drinking water standards and distribute water. The company also owns and operates three wastewater collection systems and twelve wastewater collection and treatment systems. The company operates within its franchised water and wastewater territory, which covers portions of municipalities within four counties in south-central Pennsylvania. It provides services to diversified, manufacturing such items as fixtures and furniture, electrical machinery, food products, paper, ordnance units, textile products, air conditioning systems, laundry detergent, barbells, and motorcycles.